Home » Newsletters » BioWorld Science

BioWorld Science

April 23, 2015

View Archived Issues

MaxCyte and Johns Hopkins University form CAR T-cell therapy immuno-oncology collaboration

TAS-4464, a new agent to treat multiple myeloma

E-selectin/CXCR4 dual antagonist shows antitumor activity

AACR and cancer charities fund DNA repair initiative against ovarian cancer

Astellas and Potenza Therapeutics to collaborate on immuno-oncology therapeutics

Icon Bioscience's extended-release dexamethasone reduces inflammation after cataract surgery

GenVec collaborates with LMIV on malaria vaccines

PPMD funds functional analysis of dystrophin spectrin-like repeats and effects of exon skipping

Anti-CD22-pyrrolobenzodiazepine ADC shows antitumor activity in vivo

Mission Therapeutics describes novel UCH-L1 inhibitors tested in vivo

Tolerability, activity of antibody-drug conjugate SAR-408701 encourage clinical development

First patient safety and pharmacokinetic data reported for LOXO-101

Capricor stem cell product given FDA orphan status for Duchenne muscular dystrophy

Cantrixil named orphan drug by FDA for ovarian cancer

SRX-1177 designated orphan drug in U.S. for metastatic melanoma

Ono Pharmaceutical requests squamous NSCLC indication for nivolumab

Phase I/IIa clinical trial initiated of dual FLT3/MEK inhibitor for hematologic malignancies

Post-hoc trial analyses enable Kamada to progress with inhaled AAT

FDA approves filgrastim for myelosuppression in acute radiation injury

Mnemosyne Pharmaceuticals discloses NR2A antagonists

Aurigene divulges PD-1 signaling pathway inhibitors

Trefoil Therapeutics patents modified FGFs

Canadian scientists describe novel lincRNAs and siRNAs

Dutrebis approved in E.U. for HIV-1 infection

Russian scientists present novel protein kinases inhibitors

OncoMed starts phase II trial of demcizumab in first-line metastatic pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026